MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m

MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m

Medical software group MedAdvisor (ASX: MDR) is prepared to massively dilute current shareholdings to secure the funds for a $49 million acquisition of Adheris LLC.

The Melbourne-based company has entered into a binding agreement to acquire the business from Syneos Health for US$34.5 million, in a move that would make it a leader in tailored opt-out, direct-to-patient medication adherence programs in the US.

Within months of receiving the green light to roll out its technology for eScripts in Australia, an emboldened MedAdvisor is embarking on a capital raise at a 12.5 percent premium - not a discount - to raise $45 million.

That figure is just the target of the offer, which is not underwritten and could feasibly mean the issuance of 161.11 million new shares, implying a value of $72.5 million at the offer price of $0.45 per share.

To put this planned dilution in context, MDR's market capitalisation at its current share price is just shy of $100 million.

The board of MedAdvisor is clearly sold on the benefits of Adheris' technology and the potential for its own IP to make headway in North America, highlighting an addressable network of more than 180 million and 25,000 pharmacies in the US that represent 57 per cent of the country's prescriptions.

This deal would save MedAdvisor a great deal of effort integrating with US pharmacies and electronic health records given Adheris already has networks in place.

The two companies have already been integrating live or nightly data feeds with 27 chains since establishing a strategic partnership in 2019.

"Medication non-adherence is a multi-billion-dollar global market with a lack of global players working to solve it," says MedAdvisor CEO and managing director Robert Read.

"The US represents about 40 per cent of the world's medicines market and Adheris has the potential to reach 1 in 2 Americans through its opt out patient programs."

He describes the acquisition of a strategically aligned partner like Adheris will be transformational for MedAdvisor, and this is both in terms of scale and revenues.

"This acquisition primes MedAdvisor to become a genuine global player with scale in medication adherence, helping millions of patients around the world improve their health outcomes," he says.

Adheris' current president John Ciccio set to run the US business under the agreement, including MedAdvisor's US subsidiary.

Meanwhile, MedAdvisor's chief revenue officer Steve Watt has resigned.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

New report reveals 68 per cent of businesses are vulnerable to a cybersecurity attack

Partner Content
36 per cent of employees fear their organisation is at risk of financial losse...
SAI Global
Advertisement

Related Stories

Aurizon bulks up with $2.3 billion acquisition of One Rail Australia

Aurizon bulks up with $2.3 billion acquisition of One Rail Australia

Australia’s largest rail freight operator Aurizon (ASX: AZJ) ...

Brisbane Young Entrepreneur Awards set for record crowd tonight

Brisbane Young Entrepreneur Awards set for record crowd tonight

As a sign that business is flourishing in Australia's next Olym...

Qantas dusts off fleet to resume international flights ahead of schedule

Qantas dusts off fleet to resume international flights ahead of schedule

Qantas Airways (ASX: QAN) is gearing up to spread its wings much ea...

As Melbourne cautiously opens up today, what lies ahead?

As Melbourne cautiously opens up today, what lies ahead?

This morning, Melburnians are waking up to the end of the city&rsqu...